CC
ZBH icon

CQS Cayman’s Zimmer Biomet ZBH Stock Holding History

CQS Cayman’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-56,206
Closed -$6.57M – 147
2016
Q2 		$6.57M Sell
56,206
-6,219
-10% -$704K 0.58% 46
2016
Q1 		$6.46M Buy
+62,425
New +$6.04M 0.65% 43
2014
Q4 		– Sell
-26,265
Closed -$2.56M – 185
2014
Q3 		$2.56M Hold
26,265
– – 0.15% 101
2014
Q2 		$2.65M Buy
+26,265
New +$2.56M 0.16% 78

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CQS Cayman's ZBH Position: Q3 2016 in Review

CQS Cayman sold out of Zimmer Biomet (ZBH) in Q3 2016, closing a stake of 56,206 shares — an estimated $6.57M sold.

CQS Cayman first reported a position in ZBH in Q2 2014 and held it in 4 quarters. The position peaked at $6.57M in Q2 2016. 808 funds tracked by Wall St. Rank hold ZBH as of Q3 2016.

  • CQS Cayman reported no remaining Zimmer Biomet position as of Q3 2016 after selling out during the quarter.
  • CQS Cayman sold 56,206 Zimmer Biomet shares in Q3 2016, an estimated $6.57M.
  • CQS Cayman first reported a position in Zimmer Biomet in Q2 2014 and held it in 4 quarters.
  • CQS Cayman's Zimmer Biomet position peaked at $6.57M in Q2 2016.
  • 808 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2016.

Based on CQS Cayman's 13F filing for Q3 2016, filed 14 Nov 2016.